Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients
Open Access
- 19 February 2008
- journal article
- research article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 8 (1) , 5
- https://doi.org/10.1186/1471-2288-8-5
Abstract
Electronic monitoring (EM) is used increasingly to measure medication non-adherence. Unbiased EM assessment requires fulfillment of assumptions. The purpose of this study was to determine assumptions needed for internal and external validity of EM measurement. To test internal validity, we examined if (1) EM equipment functioned correctly, (2) if all EM bottle openings corresponded to actual drug intake, and (3) if EM did not influence a patient's normal adherence behavior. To assess external validity, we examined if there were indications that using EM affected the sample representativeness. We used data from the Supporting Medication Adherence in Renal Transplantation (SMART) study, which included 250 adult renal transplant patients whose adherence to immunosuppressive drugs was measured during 3 months with the Medication Event Monitoring System (MEMS). Internal validity was determined by assessing the prevalence of nonfunctioning EM systems, the prevalence of patient-reported discrepancies between cap openings and actual intakes (using contemporaneous notes and interview at the end of the study), and by exploring whether adherence was initially uncharacteristically high and decreased over time (an indication of a possible EM intervention effect). Sample representativeness was examined by screening for differences between participants and non-participants or drop outs on non-adherence. Our analysis revealed that some assumptions were not fulfilled: 1) one cap malfunctioned (0.4%), 2) self-reported mismatches between bottle openings and actual drug intake occurred in 62% of the patients (n = 155), and 3) adherence decreased over the first 5 weeks of the monitoring, indicating that EM had a waning intervention effect. The validity assumptions presented in this article should be checked in future studies using EM as a measure of medication non-adherence.Keywords
This publication has 23 references indexed in Scilit:
- Prevalence and Risk Factors of Non-Adherence with Immunosuppressive Medication in Kidney Transplant PatientsAmerican Journal of Transplantation, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Race and Electronically Measured Adherence to Immunosuppressive Medications after Deceased Donor Renal TransplantationJournal of the American Society of Nephrology, 2005
- Use of Electronic Monitoring Devices to Measure Antiretroviral Adherence: Practical ConsiderationsAIDS and Behavior, 2005
- Prevalence and Correlates of Nonadherence to Antiretroviral Therapy in a Population of HIV Patients Using Medication Event Monitoring System®AIDS Patient Care and STDs, 2004
- Electronic monitoring: Adherence assessment or intervention?HIV Research & Clinical Practice, 2002
- Microelectronic Systems for Monitoring and Enhancing Patient Compliance With Medication RegimensDrugs, 1995
- Critical Comparison of Novel and Existing Methods of Compliance Assessment During a Clinical Trial of an Oral Iron ChelatorThe Journal of Clinical Pharmacology, 1994
- Compliance with prescribed drug therapy in asthmaRespiratory Medicine, 1994
- The Effects of Monitoring and Feedback on ComplianceMedical Care, 1990